首页 正文

An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016-present)

{{output}}
Introduction: Rearranged during transfection (RET) is a transmembrane receptor tyrosine kinase. Aberrations in RET signaling due to mutations, gene fusions, or overexpression can lead to carcinomas. Six inhibitors have been appro... ...